Loading candles…
Strides Pharma Science Ltd operates in the pharmaceutical industry, specializing in the development and manufacturing of pharmaceutical products and niche finished dosage formulations. Its product range includes complex generics across multiple dosage forms such as tablets, hard capsules, sachets, liquids, nasal sprays, topicals, and controlled substances. The company distributes its products in over 100 countries and maintains a manufacturing presence with seven facilities spanning four continents, of which four are approved by the US FDA. Strides Pharma Science Ltd has pursued an inorganic growth strategy to enter new markets, expand business and therapy segments, and enhance manufacturing infrastructure.
This page is a live market overview for STRIDES PHARMA SCI LTD (STAR) on the NSE. As a listed security, STRIDES PHARMA SCI LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for STAR before placing trades on tick2trade.
As of the latest feed, STAR last traded at ₹1,003.8 on NSE, up ₹6.6 (0.66%) from the previous close of ₹997.2. Today's session range is ₹991 – ₹1,019.7, against a 52-week band of ₹768.65 – ₹1,231. Traded volume today stands at 2.61L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for STAR in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether STAR is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for STRIDES PHARMA SCI LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in STAR. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated STAR option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 18 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 30 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 29 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.